214
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          This study aims to review the literature regarding the barriers to sampling, recruitment, participation, and retention of members of socioeconomically disadvantaged groups in health research and strategies for increasing the amount of health research conducted with socially disadvantaged groups.

          Methods

          A systematic review with narrative synthesis was conducted. Searches of electronic databases Medline, PsychInfo, EMBASE, Social Science Index via Web of Knowledge and CINHAL were conducted for English language articles published up to May 2013. Qualitative and quantitative studies as well as literature reviews were included. Articles were included if they reported attempts to increase disadvantaged group participation in research, or the barriers to research with disadvantaged groups. Groups of interest were those described as socially, culturally or financially disadvantaged compared to the majority of society. Eligible articles were categorised according to five phases of research: 1) sampling, 2) recruitment and gaining consent, 3) data collection and measurement, 4) intervention delivery and uptake, and 5) retention and attrition.

          Results

          In total, 116 papers from 115 studies met inclusion criteria and 31 previous literature reviews were included. A comprehensive summation of the major barriers to working with various disadvantaged groups is provided, along with proposed strategies for addressing each of the identified types of barriers. Most studies of strategies to address the barriers were of a descriptive nature and only nine studies reported the results of randomised trials.

          Conclusions

          To tackle the challenges of research with socially disadvantaged groups, and increase their representation in health and medical research, researchers and research institutions need to acknowledge extended timeframes, plan for higher resourcing costs and operate via community partnerships.

          Related collections

          Most cited references148

          • Record: found
          • Abstract: found
          • Article: not found

          Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.

          Racial and ethnic minorities, older adults, rural residents, and individuals of low socioeconomic status are underrepresented among participants in cancer-related trials. The authors conducted a systematic review to determine the barriers to participation of underrepresented populations in cancer-related trials. Their search included English-language publications that reported original data on the recruitment of underrepresented groups to cancer treatment or prevention trials between 1966 and December 2005 in multiple electronic databases. They also hand-searched titles in 34 journals from January 2003 to December 2005 and they examined reference lists for eligible articles. Titles and abstracts were reviewed to identify relevant studies. Data on barriers to participation were synthesized both qualitatively and based on statistically significant associations with trial enrollment. Of 5257 studies that were cited, 65 studies were eligible for inclusion in the current analysis, including 46 studies on recruitment into cancer therapeutic trials, 15 studies on recruitment into prevention trials, and 4 studies on recruitment into both prevention and treatment trials. Numerous factors were reported as barriers to participation in cancer-related trials. However, only 20 of the studies reported statistically significant associations between hypothesized barriers and enrollment. The available evidence had limitations in quality regarding representativeness, justification of study methods, the reliability and validity of data-collection methods, potential for bias, and data analysis. The results indicated that underrepresented populations face numerous barriers to participation in cancer-related trials. The current systematic review highlighting the literature on recruitment of underrepresented populations to cancer trials and may be used as the evidence base toward developing an agenda for etiologic and intervention research to reduce the disparities in participation in cancer-related trials.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Interventions to improve research participants' understanding in informed consent for research: a systematic review.

            Available data suggest that prospective research participants may frequently not understand information disclosed to them in the informed consent process. Little is known about how understanding can be improved. To review research on interventions to improve research participants' understanding of information disclosed in the informed consent process. A search of MEDLINE was performed using the terms informed consent and clinical research and informed consent and (comprehension or understanding) from 1966 to March 2004 , which included randomized controlled trials, longitudinal trials, and controlled trials with nonrandom allocation that compared the understanding of research participants who had undergone only a standard informed consent process to that of participants who had received an intervention to improve their understanding. A comprehensive bibliography of empirical research on informed consent published in January 1999 was also reviewed, as were personal files and all issues of the journals IRB and Controlled Clinical Trials. Study design, quality criteria, population characteristics, interventions, and outcomes for each trial were extracted. The statistical significance of the interventions' effects on understanding were noted, as were mean scores for understanding for each group of each trial. For those trials that measured the secondary outcomes of satisfaction and willingness to enroll, results were also summarized. Thirty studies described 42 trials that met inclusion criteria. Of 12 trials of multimedia interventions, 3 showed significant improvement in understanding. Of 15 trials of enhanced consent forms, 6 showed significant improvement in understanding (all P<.05), but 5 of 6 trials were of limited quality, casting doubt on their practical relevance. Of 5 trials of extended discussion, 3 showed significant improvement in understanding (all P<.001) and 2 showed trends toward improvement (P=.054 and P=.08). Of 5 trials of test/feedback, all showed significant improvement in understanding (all P<.05) but were flawed in that they may have mistaken rote memorization for improvement in understanding. Another 5 trials were put into a miscellaneous category and had varying impact on understanding. Some demographic factors, particularly lower education, were associated with less understanding. Satisfaction and willingness to enroll were never significantly diminished by an intervention . Efforts to improve understanding through the use of multimedia and enhanced consent forms have had only limited success. Having a study team member or a neutral educator spend more time talking one-on-one to study participants appears to be the most effective available way of improving research participants' understanding; however, further research is needed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Are Racial and Ethnic Minorities Less Willing to Participate in Health Research?

              Introduction To ensure the generalizability of research results, it is important that all groups participate in health research [1–4]. However, many commentators claim that racial and ethnic minority groups, especially in the US, are less willing to participate in health research [5–13]. While the US population includes an increasing percentage of individuals from minority groups, non-Hispanic whites still compose a majority of the population (Figure 1). It is widely believed that racial and ethnic minority groups in the US, especially African-Americans, are less willing than non-Hispanic whites to participate in health research. Many commentators believe that this relative unwillingness traces to past abuses, especially the notorious Tuskegee Syphilis Study [14–18], described as “the singular reason behind African-American distrust of the institutions of medicine and public health” [19]. The claim that racial and ethnic minority groups in the US are less willing to participate in health research seems to be validated by data showing that minority groups are underrepresented in at least some health research studies [20–25]. Yet, willingness to participate is just one factor that influences whether individual patients and patient groups participate in health research [9,26]. Other factors include whether they are informed of research opportunities, whether they are medically eligible to participate, and whether their personal circumstances, including child care demands, job flexibility, and geographic proximity to research sites, allow them to participate. Simply assuming that minority groups' underrepresentation in some health studies is a result of their being less willing to participate may focus efforts aimed at increasing their participation on changing minority attitudes. If, however, minorities are equally willing to participate, and their lower participation in some studies traces to other factors, these efforts may prove ineffective, or even counterproductive. The assumption that minority groups are less willing to participate in health research also may inadvertently increase stigmatization, suggesting that minority groups are unwilling to bear their fair share of the burdens required to improve medical care. A few studies have assessed the willingness of racial and ethnic minority groups to participate in individual research trials and trials that focus on single diseases [7,27,28]. However, we could find no published empirical data on the actual consent rates of minority groups for health research in general. To evaluate the widespread claim that racial and ethnic minorities are less willing to participate in health research, we assessed whether individuals from minority groups who were eligible and invited to participate in health research consented to enroll less frequently than non-Hispanic whites. Methods Non-Intervention Studies The Tuskegee Syphilis Study, thought to be a major reason, particularly in the US, behind racial and ethnic minority groups' presumed unwillingness to participate in health research, was a US government-funded, epidemiologic study. To assess racial and ethnic minority groups' willingness to participate in current US government-funded, epidemiologic studies, we evaluated the health surveys conducted by the US National Center for Health Statistics (NCHS) for the most recent year for which data were available, year 2000. The NCHS, the nation's principal health statistics agency, conducts two ongoing population based health surveys—the National Health Interview Survey (NHIS) and the National Health and Nutrition Examination Survey (NHANES). The NCHS, in collaboration with the National Immunization Program, also conducts the National Immunization Survey (NIS), which collects data that can be used to determine consent rates by race. The other health surveys conducted by the NCHS did not qualify for analysis, either because they are based on the NHIS sample, or because they are based on administrative records, not direct contact with individuals. Thus, three survey or non-intervention studies conducted by the NCHS that provide data on consent rates by race or ethnicity are included in the analysis. The NHIS is an annual, in-person, household interview, designed to produce data representative of the civilian, non-institutionalized population of the US [29]. The sample consists of approximately 106,000 persons, in approximately 43,000 households in over 300 primary sampling units. The first part of the survey collects basic demographic and health data on all members of the household. A sample adult and child are then selected from each household to complete a more detailed interview that assesses illness, health-care utilization, and socioeconomic and demographic factors. All households selected into the sample are visited by interviewers to introduce the study and conduct a brief interview to determine eligibility. Data on race and ethnicity are collected at this initial contact. The NHIS invites a higher percentage of African-Americans and Hispanics to participate than the percentage of these two groups in the US population. Interview response rates were calculated for sample adults for whom demographic information was obtained during the initial contact. The NHIS neither conducts public outreach nor provides financial incentives. The NIS is an annual, random-digit-dialing telephone survey of approximately 34,000 US households with at least one child 19–35 mo old [30]. After answering questions about the resident child's immunization status, participants are asked for approval to contact providers to obtain the child's immnunization records. The NIS neither conducts public outreach nor provides financial incentives. The NHANES is an annual nationally representative sample survey of approximately 5,000 non-institutionalized US civilians. Extensive media and public outreach are conducted in each community to familiarize potential participants with the survey. The household interview component of the NHANES assesses respondents' health, health-care utilization, and demographic characteristics [31]. Participants do not receive any financial incentives for the interview portion of the NHANES. Individuals who complete the interview portion of the NHANES are invited to participate in an extensive medical examination, which requires a separate consent. The medical examination lasts approximately 4 h and includes a physical examination and a second interview. The physical examination collects blood and urine samples for laboratory tests such as cholesterol levels, blood lead levels, and levels of exposure to other environmental health hazards. The interview includes questions on physical health, mental health, sexual behavior, and drug use. Participants who complete the physical examination receive $70–$100 for their time and effort. Because individuals must have already consented to the NHANES interview to be invited to participate in the medical examination, the consent rates for the medical examination are listed (Table 1), but not included in the overall statistical analysis. Health Intervention Studies Because there are no databases of health intervention trials, we conducted a comprehensive literature search of published trials. Using PubMed (http://www.ncbi.nlm.nih.gov/entrez/), we searched 30 unique combinations of terms and strings of terms related to enrollment, refusal, race, and ethnicity in phase I trials, phase I/II trials, phase II trials, and randomized controlled trials (see Table S1 for search terms). Studies were eligible for inclusion if they documented the race or ethnicity of eligible individuals invited to enroll, as well as the race or ethnicity of those who actually enrolled. Two authors (G. V. and C. P. G.) reviewed the titles of all 1,681 articles identified by the search terms, then retrieved abstracts for the 1,106 articles that included any terms related to consent rates, including “consent,” “eligible,” “refusal,” or “enrollment” (see Figure S1 for a description of the selection process). The abstracts of all 1,106 retrieved articles were reviewed for any terms or phrases suggesting that they might include data by race or ethnicity, including “race,” “ethnicity,” “Caucasian,” “African-American,” “Hispanic,” and “non-Hispanic white.” The full texts of the 68 articles that included any of these terms were reviewed to determine whether they included data on consent rates by race or ethnicity, yielding 17 unique articles. Next, Web of Science was used to search for authors whose names appeared in the citations of two or more of the 17 identified articles, yielding 371 articles (see Table S2). Using the same selection process, the bibliographies of the 17 identified articles were reviewed for any articles mentioning consent or participation rates, yielding another 89 articles. The same two authors (G. V. and C. P. G.) repeated the selection process to search the original 1,681 articles to determine whether any of these additional 467 articles included data on consent rates by race or ethnicity. This search yielded no additional articles. Finally, to assess whether our search missed any studies that document consent rates by race or ethnicity, we evaluated the articles published for an entire year for two different types of trials. First, we reviewed all randomized controlled trials published during the 1-y period beginning April 1, 1999, in four major clinical journals: Annals of Internal Medicine, JAMA, The Lancet, and The New England Journal of Medicine. Because we wanted to assess individual patients' willingness to enroll in health research, trials were included only if they used individual patients as the unit of randomization (as opposed to hospital, region, etc.). This search identified 172 articles. We next conducted a MedLine search to identify all phase I oncology trials that used safety as an endpoint, published in English in the year 2002. This search identified 250 articles. Using the same search process that was used for the original 1,681 studies, all 422 so identified articles were reviewed to determine whether any documented consent rates by race or ethnicity. This search yielded one study that documented consent rates by race, which had been identified previously by our original MedLine search. The fact that this search of the published articles for an entire year for two different types of intervention trials did not yield any new articles suggests that our original search likely identified all studies published in English that documented consent rates by race or ethnicity. Statistical Analysis We defined the consent rates for a given study as the number of individuals in each reported racial or ethnic group who agreed to participate in the study divided by the number of individuals in that group who were invited to participate. The identified studies classified minority groups in four different ways: (1) African-Americans and Hispanics classified separately; (2) only African-Americans classified; 3) African-Americans classified separately and all other minorities grouped together; 4) all minorities grouped together. Because the original studies used different race/ethnic classifications, the minority group(s) to which non-Hispanic whites are compared in the present analysis varies across the studies. For each study, we calculated an odds ratio (OR) and the associated 95% confidence interval (CI) using non-Hispanic whites as the reference group. The OR specifies, for each study, whether the reported minority group was more or less likely to consent to enrollment than non-Hispanic whites. An OR greater than one indicates that the minority group was more likely to consent than non-Hispanic whites; an OR of less than one indicates that the minority group was less likely to consent. A DerSimonian–Laird random effects model was used to estimate the summary OR and 95% CI for each type of study (i.e., non-intervention studies, clinical intervention studies, and surgical intervention studies), again using non-Hispanic whites as the reference group [32]. We considered the summary OR to be statistically significant if the 95% CI did not include one. We also used the following statistic to test for statistical significance: where is the estimated summary OR and s * is the estimated standard deviation of the log summary OR. Under the null hypothesis that Λ = 1, X has a χ2 distribution with one degree of freedom. We also tested for homogeneity by calculating a Breslow–Day χ2 statistic. Results We found 20 health research studies that included sufficient data to determine consent rates by race or ethnicity. Eighteen of the twenty studies were single-site studies conducted exclusively in the US or multi-site studies where the majority of sites (i.e., at least 2/3) were in the US. Of the remaining two studies, the Concorde study was conducted at 74 sites in the United Kingdom, Ireland, and France, while the Delta study was conducted at 152 sites in Europe and 23 sites in Australia and New Zealand. Taken together, these 20 studies reported the enrollment decisions of over 70,000 individuals, the vast majority of whom were from the US, for a broad range of health research studies, from interviews and non-intervention studies to drug treatment and surgical trials. For the three interview or non-intervention studies, African-Americans had a nonsignificantly lower overall consent rate than non-Hispanic whites (82.2% versus 83.5%; OR = 0.92; 95% CI 0.84–1.02; Table 1; Figure 2). For these same three studies, Hispanics had a nonsignificantly higher overall consent rate than non-Hispanic whites (86.1% versus 83.5%; OR = 1.37; 95% CI 0.94–1.98; Figure 3). Additionally, there was a significant lack of homogeneity for both comparisons (i.e., the test of homogeneity of the OR was rejected). A lack of homogeneity indicates that the relative willingness to enroll of minority groups versus non-Hispanic whites was not consistent, but varied significantly within the group of studies. For the ten clinical intervention studies, African-Americans had a nonsignificantly higher overall consent rate than non-Hispanic whites (45.3% versus 41.8%; OR = 1.06; 95% CI 0.78–1.45; Table 2; Figure 2). Again, there was a significant lack of homogeneity among the ORs, indicating that the relative willingness to enroll of minority groups versus non-Hispanic whites varied significantly within the group of studies. For these same ten studies, Hispanics had a statistically significant higher overall consent rate than non-Hispanic whites (55.9% versus 41.8%; OR = 1.33; 95% CI 1.08–1.65; Figure 3). Table 3 reports the consent rates for the seven surgical intervention studies, which categorized all minority groups together. For these seven trials, minorities as a group had a nonsignificantly higher overall consent rate than non-Hispanic whites (65.8% versus 47.8%; OR = 1.26; 95% CI 0.89–1.77; Figure 4). While the test of homogeneity was only nominally significant (p = 0.046), six of the seven ORs were greater than one. Importantly, of the 20 studies identified, seven offered enrollment to very few minority individuals. For example, the BARI study of percutaneous transluminal coronary angioplasty versus coronary artery bypass graft for coronary artery disease offered enrollment to 3,832 non-Hispanic whites, but to only 16 individuals from all minority groups combined (Table 3). Similarly, the CASS study of surgery versus medical management for angina pectoris offered enrollment to 2,065 non-Hispanic whites, but to only 30 individuals from all minority groups (Table 3). Discussion We identified 20 health research studies that reported the consent rates by race or ethnicity of over 70,000 individuals, the vast majority of whom were from the US. These 20 studies reveal small differences in the rates at which non-Hispanic whites and minorities agree to participate in health research. Indeed, where there are differences in consent rates, individuals from minority groups tend to be slightly more willing to participate in health research, particularly for clinical and surgical intervention studies. These findings contradict the widely held view that racial and ethnic minority groups in the US are less willing than non-Hispanic whites to participate in health research. Our findings are striking given that they represent the enrollment decisions of over 70,000 individuals, including over 14,000 individuals who were invited to participate in clinical and surgical intervention trials. Furthermore, although we found only 20 studies that reported consent rates by race or ethnicity, these studies represent a broad range of invasiveness and risk, from in-person interviews and medical chart reviews, to drug treatment and surgical trials. These studies also cover a broad range of conditions, including recurrent throat infection, substance abuse, schizophrenia, HIV infection, cancer, and cardiac diseases. Studies suggest that various factors, including historic abuses like the Tuskegee study, may have undermined minority groups' trust in medical research, as measured by survey questions and focus groups [33,34]. These factors may have increased individuals' suspicions or decreased their level of trust. However, the present analysis reveals that these factors have not resulted in racial and ethnic minorities in the US being less willing to participate in health research [35]. Although we found only small differences in consent rates by race or ethnicity, we did find substantial differences by race and ethnicity in the number of individuals invited to participate. In particular, seven of the 17 clinical and surgical intervention studies offered enrollment to relatively few individuals from minority groups, substantially fewer than one would expect based on the percentage of the population composed of minority groups and the incidence of the diseases being studied. For instance, the CASS study of surgery versus medical management for angina pectoris offered enrollment to a total of 2,095 individuals, 2,065 of whom were non-Hispanic whites and only 30 of whom were from all minority groups combined. Yet, as of 1980, 17% of the U.S. population belonged to a minority group, and the estimated prevalence of angina pectoris is higher in minority groups, especially African-Americans and Hispanics, than in non-Hispanic whites [36]. Recognizing that this rough estimate of minority representation in the US fails to take into account other relevant considerations, US demographics and the prevalence of angina pectoris suggest that the CASS study, which recruited individuals in the late 1970s, should have offered enrollment to approximately 356 individuals from minority groups (17% of 2,095), more than ten times the 30 individuals from minority groups actually offered enrollment [37]. Looking at the number of individuals who participated, one might conclude that these studies support the thesis that minorities are less willing to participate in health research in the US. This conclusion is contradicted by the studies' actual consent rates. In the BARI study, individuals from minority groups agreed to participate at a significantly higher rate than non-Hispanic whites (62.5% versus 47.6%). Similarly, individuals from minority groups agreed to participate at a significantly higher rate than non-Hispanic whites in the CASS study (43.3% versus 37.1%). We found a significant lack of homogeneity for all pooled statistics, with the exception of Hispanics' and non-Hispanic whites' comparative willingness to enroll in clinical intervention trials. This lack of homogeneity indicates that the relative willingness to enroll of minority groups versus non-Hispanic whites varies significantly within the various groups of studies. The lack of homogeneity suggests that comparative willingness to enroll in specific studies cannot be inferred simply from the type of study, or the racial or ethnic groups in question. Instead, it appears that individuals from minority groups are more willing to enroll in some studies, and non-Hispanic whites are more willing to enroll in others. This finding suggests that willingness to enroll often is more a function of the characteristics of individual studies than a function of racial or ethnic identity. Hence, in cases where a study has difficulty enrolling individuals from a particular group, whether a minority group or non-Hispanic whites, it will be important to assess whether particular characteristics of the study account for this difference. For example, choice of study site may have an important impact on which groups are likely to enroll. Also, the lack of homogeneity suggests that it may be important to conduct further research to determine which characteristics of studies influence the willingness of racial and ethnic groups to participate. Numerous writers have emphasized the need to increase minority participation in health research [38–42]. Such efforts are important for reasons of justice, and to ensure research findings are generalizable to the entire population. These efforts are especially important given data that minority groups are not represented adequately in some clinical trials [1–4,25]. If efforts to increase minority participation are to succeed, it is vital to understand why minority groups are underrepresented in some research trials. Widespread discussion of past abuses, and racial and ethnic minorities' presumed unwillingness to participate, has focused attention on the attitudes of individuals from minority groups. However, the current data suggest individuals from minority groups, at least in the US, are as willing as non-Hispanic whites to participate in health research when eligible and invited to participate. This finding suggests that any underrepresentation of minority groups in health research, when it occurs, is likely the result of other factors, such as the fact that some studies invite comparatively few individuals from minority groups to participate [43]. Consequently, efforts to increase minority participation in health research should focus on increasing minority access to research participation, not changing minority attitudes [44–47]. To be successful, these efforts should take into account a number of considerations [48]. Informing minority groups of specific trials and inviting them to participate is an obvious step. In addition, health research trials should try to include sites that are accessible to minority groups, and identify and attempt to address factors that may undermine minority groups' participation in particular, such as the need for child care and reimbursement for travel expenses. Language barriers also may pose difficulties with recruiting some minority groups [49]. Several limitations suggest the need for future research. First, the current findings are limited to published articles that documented consent rates by race or ethnicity. Second, the vast majority of the over 70,000 individuals in the present analysis were from the US. The willingness of minority groups from other countries to participate in health research may differ from the willingness of minority groups in the US. For example, time and cost constraints may preferentially reduce the willingness of individuals from minority groups to participate in health research in general. Yet, this factor may be outweighed in the US by the fact that health care is not guaranteed, and individuals from minority groups may be more likely to use participation in research as a way to obtain access to physicians and health care. Third, we did not assess minority groups' attitudes toward health research. The current findings do not rule out the possibility that past abuses have resulted in individuals from minority groups being more distrustful of health research than non-Hispanic whites. It may be that past abuses have led to greater distrust among minority groups, but that other factors result in individuals from minority groups being equally willing to participate overall. For instance, some minority groups are more likely to be from lower socioeconomic groups, and individuals from lower socioeconomic groups may be comparatively more willing to participate in research for a number of possible reasons, including a stronger sense of social obligation or to gain access to health treatments. Fourth, our comprehensive search focused on clinical intervention trials, specifically phase I, phase I/II, phase II, and randomized controlled trials. Our search did not include prevention trials and natural history studies. Individuals from minority groups may be less willing than non-Hispanic whites to participate in these types of studies. It is widely believed that racial and ethnic minorities are less willing to participate in health research. Such claims often focus on the US, where it is believed that minority groups' relative unwillingness to participate in health research traces to historic abuses, especially the notorious Tuskegee Syphilis Study. We found that racial and ethnic minorities in the US, particularly African-Americans and Hispanics, are as willing to participate, and in some instances more willing to participate, in health research than non-Hispanic whites, when eligible and invited to participate. These findings suggest that efforts to remedy any underrepresentation of minority groups in health research should focus on ensuring equal access to health research for all groups, not on changing attitudes. Efforts to increase minority groups' access to clinical research studies should focus on a range of considerations, including inviting minority groups to participate, using sites accessible to minority groups, and identifying and attempting to address factors that may undermine the participation of individuals from minority groups, such as the need for child care or reimbursement of travel expenses. Supporting Information Figure S1 Selection Process of Clinical Intervention Studies Identified by PubMed Search (26 KB DOC). Click here for additional data file. Table S1 PubMed Search Terms (63 KB DOC). Click here for additional data file. Table S2 Web of Science Search Terms Citation Search (44 KB DOC). Click here for additional data file. Patient Summary Background Health research is meant to determine the best strategies for preventing and treating disease and to inform health policy. Approval of new drugs and health guidelines is usually issued at a national level. Many countries have ethnically and racially diverse populations, and we know that health parameters are not the same for the different groups. To make sure that health policies serve a diverse population, it is important that all ethnic and racial groups participate in health research. Why Was This Study Done? Several studies have found that minority groups, especially in the US, are often underrepresented in research studies. One possible explanation that has been suggested is that because of past abuses (especially of African-Americans in the notorious Tuskegee Syphilis Study), minorities are less willing to participate in medical research. The authors of this study wanted to test whether this was indeed the case. What Did the Researchers Do and Find? They looked through the health literature in a systematic way to find all recent studies that reported consent rates by race or ethnicity (every participant in health research has to give “informed consent”). They found 20 such studies, 18 of which were conducted primarily or exclusively in the US, covering a broad range of research from interview-based surveys to clinical trials. Taken together, these studies reported the decision of over 70,000 individuals who were invited to participate. The researchers then compared the consent rates (i.e., the proportion who actually agreed to participate and gave consent) among non-Hispanic whites, African-Americans, and Hispanics. They found very small differences in the overall willingness of minorities to participate in health research compared with non-Hispanic whites. However, they did find that many of the studies invited fewer minority individuals than would be representative for the US patient population. What Does This Mean? These results suggest that racial and ethnic minority groups, at least in the US, are as willing as non-minority individuals to participate in health research, but that they are underrepresented among the invited participants. Efforts to increase minority participation should therefore focus on offering participation to more minority individuals rather than focusing on changing minority attitudes. It will be important to determine why minorities are underrepresented among people invited to participate in health research. Another interesting question not answered by this study is what motivates individuals from the different groups to accept an invitation and participate in health research both in general and in a particular survey or trial. Where Can I Find More Information Online? Information on the Tuskeege study: http://www.cdc.gov/nchstp/od/tuskegee/ http://www.pbs.org/newshour/bb/health/may97/tuskegee_5-16.html http://www.npr.org/programs/morning/features/2002/jul/tuskegee/commentary.html Office of Minority Health Affairs of the US National Heart, Lung, and Blood Institute: http://www.nhlbi.nih.gov/about/omha/ Pages on minority resources and initiatives at the US National Human Genome Research Institute: http://www.genome.gov/10011199 Report on Inclusion of Women and Minorities in Research from the Office for Protection from Research Risks: http://www.hhs.gov/ohrp/humansubjects/guidance/hsdc94-01.htm
                Bookmark

                Author and article information

                Contributors
                Journal
                BMC Med Res Methodol
                BMC Med Res Methodol
                BMC Medical Research Methodology
                BioMed Central
                1471-2288
                2014
                25 March 2014
                : 14
                : 42
                Affiliations
                [1 ]School of Medicine & Public Health, Faculty of Health & Medicine, University of Newcastle, Callaghan, NSW, Australia
                [2 ]Health Behaviour Research Group, Priority Research Centre for Health Behaviour, Faculty of Health & Medicine, University of Newcastle, Callaghan, NSW, Australia
                [3 ]Cancer Council NSW, 153 Dowling Street, Woolloomooloo, Sydney, NSW, Australia
                [4 ]School of Medicine & Public Health, Calvary Mater Hospital, University of Newcastle, Level 5, McAuley Building, Callaghan 2308, NSW, Australia
                Article
                1471-2288-14-42
                10.1186/1471-2288-14-42
                3974746
                24669751
                f6988b97-9bc3-4c79-bfbf-ca651d787017
                Copyright © 2014 Bonevski et al.; licensee BioMed Central Ltd.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 30 September 2013
                : 20 March 2014
                Categories
                Research Article

                Medicine
                systematic review,medical research,vulnerable groups
                Medicine
                systematic review, medical research, vulnerable groups

                Comments

                Comment on this article